Hochschulschrift
Investigation of carborane-based derivatives as inhibitors of the breast cancer resistance protein (ABCG2)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
302, 9 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Universität Leipzig, Dissertation, 2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Leipzig
- (wann)
-
[2023?]
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2023?]
Ähnliche Objekte (12)
Investigation of Quinazoline Derivatives as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Development of New Breast Cancer Resistance Protein Inhibitors
Development of new breast cancer resistance protein inhibitors
Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer
Anticancer - effectiveness of herbal aldehyde derivatives on breast cancer cells
Total synthesis of natural HDAC inhibitors and derivatives thereof
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Monitoring CDK4/6 inhibitor resistance in metastatic breast cancer patients using liquid biopsy markers
Investigation of Phthalazine, Quinazoline and Pyrimidine Derivatives as ABCG2 Inhibitors
Investigation of Quinazoline Derivatives as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Development of New Breast Cancer Resistance Protein Inhibitors
Development of new breast cancer resistance protein inhibitors
Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer
Anticancer - effectiveness of herbal aldehyde derivatives on breast cancer cells
Total synthesis of natural HDAC inhibitors and derivatives thereof
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Monitoring CDK4/6 inhibitor resistance in metastatic breast cancer patients using liquid biopsy markers
Investigation of Phthalazine, Quinazoline and Pyrimidine Derivatives as ABCG2 Inhibitors
Investigation of Quinazoline Derivatives as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Development of New Breast Cancer Resistance Protein Inhibitors
Development of new breast cancer resistance protein inhibitors
Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer
Anticancer - effectiveness of herbal aldehyde derivatives on breast cancer cells
Total synthesis of natural HDAC inhibitors and derivatives thereof
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Design und Synthese neuartiger Inhibitoren für den ABC-Transporter Breast Cancer Resistance Protein
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Monitoring CDK4/6 inhibitor resistance in metastatic breast cancer patients using liquid biopsy markers